Cardinal Health to pay $8.8 million to resolve SEC case for bribery-related books and records violations
By Robert Thomason ( February 28, 2020, 22:48 GMT | Insight) -- Cardinal Health, an Ohio pharmaceutical firm, has agreed to pay $8.8 million to the US Securities and Exchange Commission to resolve Foreign Corrupt Practices Act books and records violations relating to alleged bribes paid to Chinese officials by a former subsidiary in the country.Cardinal Health, an Ohio pharmaceutical firm, has agreed to pay $8.8 million to the US Securities and Exchange Commission to resolve Foreign Corrupt Practices Act books and records violations relating to alleged bribes paid to Chinese officials by a former subsidiary in the country....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.